Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial Investigators.

N Engl J Med. 2013 Feb 21;368(8):709-18. doi: 10.1056/NEJMoa1113697.

2.

Super-high-dose methylprednisolone does not improve efficacy or induce glucocorticoid resistance in experimental allergic encephalomyelitis.

Wei ZS, Hong MF, Su QX, Wang XH, Yu QY, Peng ZX, Zhang MX, Jie A, Wang R, Huang YQ.

Neuroimmunomodulation. 2011;18(1):28-36. doi: 10.1159/000314736. Epub 2010 Jul 8.

PMID:
20616573
3.

Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.

Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T.

PLoS One. 2010 Jan 21;5(1):e8817. doi: 10.1371/journal.pone.0008817.

4.

Development of a new test for the global fibrinolytic capacity in whole blood.

Rijken DC, Hoegee-de Nobel E, Jie AF, Atsma DE, Schalij MJ, Nieuwenhuizen W.

J Thromb Haemost. 2008 Jan;6(1):151-7. Epub 2007 Oct 25.

PMID:
17973653
5.

Clot penetration and fibrin binding of amediplase,a chimeric plasminogen activator (K2 tu-PA).

Rijken DC, Barrett-Bergshoeff MM, Jie AF, Criscuoli M, Sakharov DV.

Thromb Haemost. 2004 Jan;91(1):52-60.

PMID:
14691568
6.

Binding and retention of polycationic peptides and dendrimers in the vascular wall.

Sakharov DV, Jie AF, Filippov DV, Bekkers ME, van Boom JH, Rijken DC.

FEBS Lett. 2003 Feb 27;537(1-3):6-10.

7.
8.

The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.

Braat EA, Collen A, Jie AF, Grimbergen JM, Rijken DC.

Biochim Biophys Acta. 2000 Sep 20;1497(3):351-8.

10.

Interaction of reteplase with heparin. A comparison between reteplase and alteplase.

Rijken DC, Jie AF.

Blood Coagul Fibrinolysis. 1996 Jul;7(5):561-6.

PMID:
8874867
11.

Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.

Rijken DC, de Munk GA, Jie AF.

Thromb Haemost. 1993 Nov 15;70(5):867-72.

PMID:
8128448
12.

Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin.

Kluft C, Jie AF, Los P, de Wit E, Havekes L.

Biochem Biophys Res Commun. 1989 Jun 15;161(2):427-33.

PMID:
2525378
13.

Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1).

de Maat MP, Kluft C, de Boer K, Knot EA, Jie AF.

Thromb Res. 1988 Dec 1;52(5):425-30.

PMID:
3146821
14.

Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency).

Cugno M, Bergamaschini L, Uziel L, Cicardi M, Agostoni A, Jie AF, Kluft C.

J Clin Chem Clin Biochem. 1988 Jul;26(7):423-7.

PMID:
3146615
15.

Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).

Kluft C, Jie AF, Rijken DC, Verheijen JH.

Thromb Haemost. 1988 Apr 8;59(2):329-32.

PMID:
3133814
16.

Association between postoperative hyper-response in t-PA inhibition and deep vein thrombosis.

Kluft C, Jie AF, Lowe GD, Blamey SL, Forbes CD.

Thromb Haemost. 1986 Aug 20;56(1):107. No abstract available.

PMID:
3095945
17.

The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood.

Kluft C, Los P, Jie AF, van Hinsbergh VW, Vellenga E, Jespersen J, Henny CP.

Blood. 1986 Mar;67(3):616-22.

18.

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.

Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO.

Scand J Clin Lab Invest. 1985 Nov;45(7):605-10.

PMID:
3934744
19.

Identification of a reversible inhibitor of plasminogen activators in blood plasma.

Kluft C, Jie AF, Sprengers ED, Verheijen JH.

FEBS Lett. 1985 Oct 14;190(2):315-8.

20.

Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.

Kluft C, Cooper P, Jie AF, Lowe GD, Forbes CD, Blamey SL, van de Putte LB.

Haemostasis. 1985;15(2):144-50.

PMID:
3874124
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk